交易 Syndax Pharmaceuticals, Inc. - SNDX CFD

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML); and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD). The company is also developing Entinostat. It also has collaborative research and development agreement with National Cancer Institute; a clinical trial agreement with Eastern Cooperative Oncology Group; and a license agreement with Kyowa Hakko Kirin Co., Ltd. The company was incorporated in 2005 and is headquartered in Waltham, Massachusetts.

最新股票文章

美國對中關稅生效後,如何交易那斯達克100指數?
美國對中關稅生效後,如何交易那斯達克100指數?
上週四的跌勢尚未完全回補,但在部分科技巨頭股價強勁反彈帶動下,美股情緒明顯回暖,投資人情緒仍以多頭偏好為主。
07:48, 7 8月 2025
中國的經濟危機比想像中還嚴重?
中國的經濟危機比想像中還嚴重?
中國經濟正面臨嚴峻困境,而這張圖清楚說明了原因。圖表顯示中國的房地產投資、新開工項目以及房屋銷售的表現。
16:41, 27 7月 2025
特斯拉財報不及預期後的交易動向
特斯拉財報不及預期後的交易動向
第二季財報盈餘與營收皆未達預期,股價在盤後交易下跌,執行長馬斯克警告可能將面臨「幾個艱難的季度」
20:07, 24 7月 2025
為何麥可·貝利(Michael Burry)剛清倉所有股票?
為何麥可·貝瑞(Michael Burry)剛剛清倉所有股票
麥可·貝瑞剛剛拋售了超過7,000萬美元的股票,清空了他的整個投資組合,只保留一支股票,並對這家公司加碼,而其他投資人則紛紛出逃。
18:37, 22 7月 2025